ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1390

Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample

Atefeh Vafa1, Omid Behnamfar2 and Yih Chang Lin3, 1University of South Florida, Tampa, FL, 2University of California San Diego, La Jolla, CA, 3University of South Florida, Morsani College of Medicine, Tampa, FL

Meeting: ACR Convergence 2020

Keywords: Mortality, Myocardial Infarction, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Several systemic autoimmune rheumatic diseases have been shown to increase coronary artery disease (CAD) risk, notable rheumatoid arthritis and systemic lupus erythematosus.  However, data on the risk of systemic sclerosis (SSc) and CAD is unclear.  Although not a common finding, some studies have shown an increased prevalence of CAD in SSc patients.  This has been attributed to the underlying vascular abnormalities.  Other studies have failed to show a significant difference in the prevalence of CAD compared to the general population.  The primary aim of this study was to assess the outcomes of SSc patients who were primarily hospitalized for acute myocardial infarction (AMI) from a nationally representative sample.

Methods: We used data from the National Inpatient Sample (NIS) for the period of 2016 to 2017 for adult AMI hospitalizations as a primary diagnosis and systemic sclerosis as a secondary diagnosis using ICD-10 codes. The proportion who met ACR classification criteria and disease activity status cannot be determined within the NIS database. We used STATA 15 for the data analysis and multivariate logistic regression to calculate the adjusted odds ratios for inpatient mortality in AMI hospitalizations.

Results: We identified a total of 1,305,889 AMI hospitalizations between 2016 and 2017 of which 1,145 (0.08%) had a diagnosis of SSc. Compared to the non-SSc group, patients with SSc were predominantly female (82.1% vs. 37.9%; p< 0.001).  There was no statistically significant difference in the age between two groups of patients.

Compared to non-SSc hospitalizations with AMI, SSc hospitalizations had a higher unadjusted inpatient mortality rate (9.17% vs. 4.68%; p=0.001). After adjusting for gender, age, race, household income, hospital location, hospital teaching status, hospital bed size and Charlson Comorbidity Index, the odds ratio (OR) for hospital mortality due to AMI in SSC patients was higher and statistically significant (aOR=2.02; 95% CI= 1.28-3.19; p=0.002) compared to the non-SSc group. Length of stay was significantly longer in patients with SSc (5.3 vs 4.4 days; p=0.038).

Conclusion: In our study, unadjusted and adjusted inpatient mortality in SSc patients primarily hospitalized for AMI was higher than non-SSc patients with an adjusted odds ratio of 2.02. This finding indicates that patients with SSc may have worse outcomes for cardiovascular events when admitted for AMI. Further study in optimizing cardiovascular risk factors in SSc patients is paramount in order to minimize their cardiac morbidity and mortality.


Disclosure: A. Vafa, None; O. Behnamfar, None; Y. Lin, None.

To cite this abstract in AMA style:

Vafa A, Behnamfar O, Lin Y. Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/outcomes-of-systemic-sclerosis-patients-who-were-primarily-admitted-for-acute-myocardial-infarction-from-2016-to-2017-insights-from-the-national-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-of-systemic-sclerosis-patients-who-were-primarily-admitted-for-acute-myocardial-infarction-from-2016-to-2017-insights-from-the-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology